MEDICINOVA INC
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
MNOV$1.47+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets: | ||
| Current assets: | ||
| Cash and cash equivalents | $40,359,738 | $50,999,442 |
| Prepaid expenses and other current assets | 714,541 | 174,938 |
| Total current assets | 41,074,279 | 51,174,380 |
| Goodwill | 9,600,240 | 9,600,240 |
| In-process research and development | 4,800,000 | 4,800,000 |
| Property and equipment, net | 25,507 | 45,800 |
| Right-of-use asset | 356,904 | 575,406 |
| Other non-current assets | 18,996 | 74,151 |
| Total assets | $55,875,926 | $66,269,977 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $1,102,494 | $1,003,937 |
| Accrued liabilities and other current liabilities | 1,662,860 | 2,059,238 |
| Operating lease liability | 193,769 | 215,926 |
| Total current liabilities | 2,959,123 | 3,279,101 |
| Deferred tax liability | 201,792 | 201,792 |
| Other non-current liabilities | 211,460 | 410,660 |
| Total liabilities | 3,372,375 | 3,891,553 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2024 and December 31, 2023; 49,046,246 and 49,046,246 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively | 49,046 | 49,046 |
| Additional paid-in capital | 479,340,901 | 478,149,161 |
| Accumulated other comprehensive loss | (135,154) | (118,090) |
| Accumulated deficit | (426,751,242) | (415,701,693) |
| Total stockholders’ equity | 52,503,551 | 62,378,424 |
| Total liabilities and stockholders’ equity | $55,875,926 | $66,269,977 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.